Brief: Zydus Lifesciences To Buy Assertio For $166.4 Million
May 13 (Reuters) - Zydus Lifesciences Ltd ZYDU.NS: ZYDUS LIFESCIENCES - UNIT TO BUY ALL OUTSTANDING SHARES OF ASSERTIO HOLDINGS ZYDUS LIFESCIENCES - TO BUY ASSERTIO FOR $23.50 PER SHARE, TOTAL $166.4 MILLION Source text: ID:nBSE1CYQtb Further company coverage: ZYDU.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Zydus Lifesciences
See all newsIndia's Zydus Lifesciences posts lower profit as expenses outpace revenue growth
Brief: Zydus Lifesciences Q2 Consol Net Profit 9.26 Billion Rupees
Brief: Zydus Lifesciences Says Zylidac Bio And Prolific Machines Partner
Brief: Zydus Lifesciences Receives U.S. FDA Approval For Estradiol And Levonorgestrel Transdermal System
Brief: Zydus Lifesciences Says Zydus Sunshine Lifesciences Signs Agreement To Establish A Pharmaceutical Manufacturing Facility In Sri Lanka